Success Stories: An Indian Postdoctoral Fellow Hired North America Immigration Law Group and Got EB1A Approved, Followed by I-485
Client’s Testimonial:
“Thank you so much for all the support and guidance thought the journey of my I-140 petition. I really appreciate that.”
On August 7th, 2021, we received another EB-1A (Alien of Extraordinary Ability) approval for a Postdoctoral Fellow in the Field of Molecular Biology (Approval Notice).
General Field: Molecular Biology
Position at the Time of Case Filing: Postdoctoral Fellow
Country of Origin: India
State of Residence at the Time of Filing: Maryland
Approval Notice Date: August 7th, 2021
Processing Time: 10 days (Premium Processing Requested)
Case Summary:
North America Immigration Law Group specializes in helping clients from varied backgrounds successfully immigrate to the US. Our team of experts assures that every client’s needs are met by taking into consideration their previous academic and professional records which are needed to model a customized petition packet. Thus, when we were approached by an Indian postdoctoral fellow working in the field of molecular biology, we made sure that we did not miss any important detail, thus helping her get not only an EB-1A (Alien of Extraordinary Ability) but also her I-485 approval from USCIS. We saw to it that we showcased all of her strong suits like follows:
- She has actively engaged her peers in the field of molecular biology by authoring and co-authoring 10 peer-reviewed journal articles that have been published in international journals of repute.
- She has conducted at least 62 reviews for journals that include Life Sciences, Cancers, Current Oncology, Genes, the International Journal of Molecular Sciences, etc. These are highly discerning journals with very stringent publishing guidelines that enlist the services of only the most accomplished researchers.
- That her publications have been cited by researchers in more than 30 countries around the world showing how reliable her ideas and research actually are.
- We submitted evidence of 218 citations, along with 4 letters from experts in the field attesting to the importance and significance of her contributions.
“[The client’s] use of molecular biology and cell-based assays to develop novel compounds, based on pyrazole linked conjugates, that are useful to treating breast cancer, cervical cancer, lung cancer, and neuroblastoma has defined her as a researcher who resides in the upper echelon of her field.”
“[The client] is responsible for some of the most compelling research on this subject in recent years. Her work with immunoconjugates has significantly expanded the field's knowledge of antibody-based cancer treatments and the utility of microRNAS as drug targets. [The client] has significantly advanced our understanding of cancer treatment, helping to improve the survival rate of thousands of Americans suffering from this debilitating and often terminal condition.”
These recommendations together with the detailed study of her career trajectory had assured us that she would qualify the thorough criteria set by USCIS in the adjudication of EB-1A petition and I-485 application. We thus, wish her the very best in her future endeavors.

